Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypertension

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    January 2018
  1. MAURI L, Kario K, Basile J, Daemen J, et al
    A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Am Heart J. 2018;195:115-129.
    PubMed     Text format     Abstract available


    October 2017
  2. WAKSMAN R, Bakris GL, Steinvil A, Garcia-Garcia H, et al
    High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
    Am Heart J. 2017;192:76-84.
    PubMed     Text format     Abstract available


    July 2017
  3. AUSTIN C, Burger C, Kane G, Safford R, et al
    High-risk echocardiographic features predict mortality in pulmonary arterial hypertension.
    Am Heart J. 2017;189:167-176.
    PubMed     Text format     Abstract available


    June 2017
  4. NEAL B, Tian M, Li N, Elliott P, et al
    Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)-A large-scale cluster randomized controlled trial.
    Am Heart J. 2017;188:109-117.
    PubMed     Text format     Abstract available


    April 2017
  5. VEMULAPALLI S, Deng L, Patel MR, Kilgore ML, et al
    National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Am Heart J. 2017;186:29-39.
    PubMed     Text format     Abstract available


  6. MORAWSKI K, Ghazinouri R, Krumme A, McDonough J, et al
    Rationale and design of the Medication adherence Improvement Support App For Engagement-Blood Pressure (MedISAFE-BP) trial.
    Am Heart J. 2017;186:40-47.
    PubMed     Text format     Abstract available


    March 2017
  7. WILLIAMS RB, Bishop GD, Haberstick BC, Smolen A, et al
    Population differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalence.
    Am Heart J. 2017;185:110-122.
    PubMed     Text format     Abstract available


  8. NAKANISHI K, Jin Z, Homma S, Elkind MS, et al
    Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.
    Am Heart J. 2017;185:85-92.
    PubMed     Text format     Abstract available


  9. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
    Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Am Heart J. 2017;185:74-84.
    PubMed     Text format     Abstract available


  10. KUPSKY DF, Ahmed AM, Sakr S, Qureshi WT, et al
    Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
    Am Heart J. 2017;185:35-42.
    PubMed     Text format     Abstract available


  11. KHETAN A, Purushothaman R, Zullo M, Gupta R, et al
    Rationale and design of a cluster-randomized controlled trial to evaluate the effects of a community health worker-based program for cardiovascular risk factor control in India.
    Am Heart J. 2017;185:161-172.
    PubMed     Text format     Abstract available


    November 2016
  12. RINNSTROM D, Dellborg M, Thilen U, Sorensson P, et al
    Hypertension in adults with repaired coarctation of the aorta.
    Am Heart J. 2016;181:10-15.
    PubMed     Text format     Abstract available


    October 2016
  13. SANGHVI K, McGrew A, Hegde K
    Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Am Heart J. 2016;180:e1-2.
    PubMed     Text format    


  14. MARTIN-CABEZAS R, Seelam N, Petit C, Agossa K, et al
    Association between periodontitis and arterial hypertension: A systematic review and meta-analysis.
    Am Heart J. 2016;180:98-112.
    PubMed     Text format     Abstract available


  15. MACIVER DH, Adeniran I, MacIver IR, Revell A, et al
    Physiological mechanisms of pulmonary hypertension.
    Am Heart J. 2016;180:1-11.
    PubMed     Text format     Abstract available


    September 2016
  16. BUCK J, Kaboli P, Gage BF, Cram P, et al
    Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
    Am Heart J. 2016;179:186-91.
    PubMed     Text format     Abstract available


  17. BHATNAGAR A, Bolli R, Johnstone BH, Traverse JH, et al
    Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
    Am Heart J. 2016;179:142-50.
    PubMed     Text format     Abstract available


  18. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    PubMed     Text format     Abstract available


    August 2016
  19. MALEBRANCHE R, Tabou Moyo C, Morisset PH, Raphael NA, et al
    Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Am Heart J. 2016;178:151-60.
    PubMed     Text format     Abstract available


  20. VEMULAPALLI S, Hellkamp AS, Jones WS, Piccini JP, et al
    Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial.
    Am Heart J. 2016;178:74-84.
    PubMed     Text format     Abstract available


  21. FROHLICH H, Nelges C, Tager T, Schwenger V, et al
    Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Am Heart J. 2016;178:28-36.
    PubMed     Text format     Abstract available


  22. AKERBLOM A, Clare RM, Lokhnygina Y, Wallentin L, et al
    Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
    Am Heart J. 2016;178:1-8.
    PubMed     Text format     Abstract available


    July 2016
  23. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    PubMed     Text format     Abstract available


    January 2016
  24. KANDZARI DE, Kario K, Mahfoud F, Cohen SA, et al
    The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Am Heart J. 2016;171:82-91.
    PubMed     Text format     Abstract available


    October 2015
  25. WEIJMANS M, van der Graaf Y, de Borst GJ, Asselbergs FW, et al
    The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk.
    Am Heart J. 2015;170:744-752.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: